| For: | Billmeier U, Dieterich W, Neurath MF, Atreya R. Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. World J Gastroenterol 2016; 22(42): 9300-9313 [PMID: 27895418 DOI: 10.3748/wjg.v22.i42.9300] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i42/9300.htm |
| Number | Citing Articles |
| 1 |
Jun-Jang Jin, Il-Gyu Ko, Lakkyong Hwang, Sang-Hoon Kim, Yong-Seok Jee, Hyeon Jeon, Su Bee Park, Jung Won Jeon. Simultaneous Treatment of 5-Aminosalicylic Acid and Treadmill Exercise More Effectively Improves Ulcerative Colitis in Mice. International Journal of Molecular Sciences 2024; 25(10) doi: 10.3390/ijms25105076
|
| 2 |
Susanna Nikolaus, Georg H. Waetzig, Sven Butzin, Monika Ziolkiewicz, Natalie Al-Massad, Florian Thieme, Ulf Lövgren, Birgitte B. Rasmussen, Torsten M. Reinheimer, Dirk Seegert, Philip Rosenstiel, Silke Szymczak, Stefan Schreiber. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases. International Journal of Colorectal Disease 2018; 33(7) doi: 10.1007/s00384-018-3069-8
|
| 3 |
Lorena Ortega Moreno, Samuel Fernández-Tomé, Raquel Abalo. Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions. Biologics 2021; 1(2) doi: 10.3390/biologics1020012
|
| 4 |
Supriya Roy, Suneela Dhaneshwar, Tarique Mahmood. Exploring the Potential of IL-1β Inhibitor Diacerein and its Combination
with 5-aminosalicylic Acid for the Possible Ameliorating Effect in TNBSinduced
Experimental Colitis in Wistar Rats. Current Drug Therapy 2022; 17(2) doi: 10.2174/1574885517666220328142715
|
| 5 |
Lorenzo Bertani, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Giovanni Baiano Svizzero, Santino Marchi, Corrado Blandizzi, Francesco Costa. Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases. Minerva Gastroenterologica e Dietologica 2020; 65(4) doi: 10.23736/S1121-421X.19.02621-7
|
| 6 |
Renata Curciarello, Guillermo H. Docena, Thomas T. MacDonald. The Role of Cytokines in the Fibrotic Responses in Crohn’s Disease. Frontiers in Medicine 2017; 4 doi: 10.3389/fmed.2017.00126
|
| 7 |
Yulia Liubomirski, Shalom Lerrer, Tsipi Meshel, Dina Morein, Linor Rubinstein-Achiasaf, David Sprinzak, Stefan Wiemann, Cindy Körner, Marcelo Ehrlich, Adit Ben-Baruch. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00804
|
| 8 |
Mayara Santa Rosa Lima, Vanessa Cristina Oliveira de Lima, Grasiela Piuvezam, Kesley Pablo Morais de Azevedo, Bruna Leal Lima Maciel, Ana Heloneida de Araújo Morais. Mechanisms of action of molecules with anti-TNF-alpha activity on intestinal barrier inflammation. Medicine 2019; 98(39) doi: 10.1097/MD.0000000000017285
|
| 9 |
Ralley E. Prentice, Emily K. Wright, Emma Flanagan, Rod W. Hunt, Gregory T. Moore, Claudia A. Nold-Petry, Sally J. Bell, Marcel F. Nold, Rimma Goldberg. The Effect of In Utero Exposure to Maternal Inflammatory Bowel Disease and Immunomodulators on Infant Immune System Development and Function. Cellular and Molecular Gastroenterology and Hepatology 2023; 16(1) doi: 10.1016/j.jcmgh.2023.03.005
|
| 10 |
Axue Wu, Yuan Gao, Ruotong Kan, Pengfei Ren, Changhu Xue, Biao Kong, Qingjuan Tang. Alginate Oligosaccharides Prevent Dextran-Sulfate-Sodium-Induced Ulcerative Colitis via Enhancing Intestinal Barrier Function and Modulating Gut Microbiota. Foods 2023; 12(1) doi: 10.3390/foods12010220
|
| 11 |
Xuhui Tong, Yuanyuan Zheng, Yu Li, Yongjian Xiong, Dapeng Chen. Soluble ligands as drug targets for treatment of inflammatory bowel disease. Pharmacology & Therapeutics 2021; 226 doi: 10.1016/j.pharmthera.2021.107859
|
| 12 |
Arushi Kohli, Alan C Moss. Personalizing therapy selection in inflammatory bowel disease. Expert Review of Clinical Immunology 2023; 19(4) doi: 10.1080/1744666X.2023.2185605
|
| 13 |
Zizhen Gong, Shengnan Zhao, Jiefei Zhou, Junkai Yan, Lingyu Wang, Xixi Du, Hui Li, Yingwei Chen, Wei Cai, Jin Wu. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production. Molecular Immunology 2018; 104 doi: 10.1016/j.molimm.2018.09.004
|
| 14 |
Johanna Pott, Agnieszka Martyna Kabat, Kevin Joseph Maloy. Intestinal Epithelial Cell Autophagy Is Required to Protect against TNF-Induced Apoptosis during Chronic Colitis in Mice. Cell Host & Microbe 2018; 23(2) doi: 10.1016/j.chom.2017.12.017
|
| 15 |
Wilbert Bouwman, Wim Verhaegh, Anja van de Stolpe. Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1008976
|
| 16 |
Aleksandra Górecka, Agnieszka Jura-Półtorak, Ewa M. Koźma, Anna Szeremeta, Krystyna Olczyk, Katarzyna Komosińska-Vassev. Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease Progression. Molecules 2024; 29(19) doi: 10.3390/molecules29194577
|
| 17 |
Hagar Ben-Yaakov, Tsipi Meshel, Metsada Pasmanik-Chor, Cindy Körner, Adit Ben-Baruch. A Tumor Microenvironment-Driven Network Regulated by STAT3 and p65 Negatively Controls the Enrichment of Cancer Stem Cells in Human HR+/HER2− Breast Cancer. Cancers 2023; 15(8) doi: 10.3390/cancers15082255
|
| 18 |
Noriko Iwamoto, Kotoko Yokoyama, Megumi Takanashi, Atsushi Yonezawa, Kazuo Matsubara, Takashi Shimada. Application of nSMOL coupled with LC‐MS bioanalysis for monitoring the Fc‐fusion biopharmaceuticals Etanercept and Abatacept in human serum. Pharmacology Research & Perspectives 2018; 6(4) doi: 10.1002/prp2.422
|
| 19 |
Don Husereau, Brian Feagan, Carl Selya-Hammer. Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching. Applied Health Economics and Health Policy 2018; 16(3) doi: 10.1007/s40258-018-0371-0
|
| 20 |
Gisa Tiegs, Andrea K. Horst. TNF in the liver: targeting a central player in inflammation. Seminars in Immunopathology 2022; 44(4) doi: 10.1007/s00281-022-00910-2
|
| 21 |
Marleen Bouhuys, Willem S. Lexmond, Patrick F. van Rheenen. De-Escalation of Anti-Tumor Necrosis Factor Alpha Agents and Reduction in Adverse Effects: A Systematic Review. Biomedicines 2022; 10(5) doi: 10.3390/biomedicines10051034
|
| 22 |
Federica Gaiani, Bianca Maria Rotoli, Francesca Ferrari, Amelia Barilli, Rossana Visigalli, Maria Clotilde Carra, Gian Luigi de’Angelis, Nicola de’Angelis, Valeria Dall’Asta. Monocytes from infliximab-resistant patients with Crohn’s disease exhibit a disordered cytokine profile. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-68993-1
|
| 23 |
Zainab Jan, Farah El Assadi, Dinesh Velayutham, Borbala Mifsud, Puthen Veettil Jithesh. Pharmacogenomics of TNF inhibitors. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1521794
|
| 24 |
Linxia Xu, Wei Liu, Xixiang Huang, Tong Sun, Letian Mei, Man Liu, Zhi Ren, Meng Wang, Hailun Zheng, Qiangwu Wang, Dapeng Li, Qizhi Wang, Xiquan Ke. Sinomenine hydrochloride improves DSS-induced colitis in mice through inhibition of the Notch signaling pathway. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03546-8
|
| 25 |
Junichi Ishida, Masakazu Saitoh, Jochen Springer. Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?. Journal of Cachexia, Sarcopenia and Muscle 2017; 8(3) doi: 10.1002/jcsm.12214
|
| 26 |
Dong-mei Yin, Dai Yuan, Rui-jie Sun, Hong-zhi Xu, Shou-yong Hun, Xiao-hui Sui, Ning-ning Shan. Identification of ORM1, vWF, SPARC, and PPBP as immune-related proteins involved in immune thrombocytopenia by quantitative LC-MS/MS. Clinical Proteomics 2023; 20(1) doi: 10.1186/s12014-023-09413-0
|
| 27 |
Thomas Klag, Jan Wehkamp, Eduard Stange. Wirkmechanismen und Wirkung von Biologika und JAK-Inhibitoren bei CED. Gastro-News 2019; 6(1) doi: 10.1007/s15036-019-0482-y
|
| 28 |
Alan C. Moss. Treatment of Inflammatory Bowel Disease with Biologics. 2018; doi: 10.1007/978-3-319-60276-9_1
|
| 29 |
Vibeke Andersen, Axel Kornerup Hansen, Berit Lilienthal Heitmann. Potential Impact of Diet on Treatment Effect from Anti-TNF Drugs in Inflammatory Bowel Disease. Nutrients 2017; 9(3) doi: 10.3390/nu9030286
|
| 30 |
Kristin K. Jørgensen, Guro L. Goll, Joe Sexton, Nils Bolstad, Inge C. Olsen, Øivind Asak, Ingrid P. Berset, Ingrid M. Blomgren, Katrine Dvergsnes, Jon Florholmen, Svein O. Frigstad, Magne Henriksen, Jon Hagfors, Gert Huppertz-Hauss, Espen A. Haavardsholm, Rolf A. Klaasen, Bjørn Moum, Geir Noraberg, Ulf Prestegård, Jan H. Rydning, Liv Sagatun, Kathrine A. Seeberg, Roald Torp, Cecilia Vold, David J. Warren, Carl M. Ystrøm, Knut E. A. Lundin, Tore Kvien, Jørgen Jahnsen. Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials. BioDrugs 2020; 34(5) doi: 10.1007/s40259-020-00438-7
|
| 31 |
Batia Weiss, Shomron Ben-Horin, Atar Lev, Efrat Broide, Miri Yavzori, Adi Lahat, Uri Kopylov, Orit Picard, Rami Eliakim, Yulia Ron, Irit Avni-Biron, Anat Yerushalmy-Feler, Amit Assa, Raz Somech, Ariella Bar-Gil Shitrit. Immune function in newborns with in-utero exposure to anti-TNFα therapy. Frontiers in Pediatrics 2022; 10 doi: 10.3389/fped.2022.935034
|
| 32 |
Raja Atreya, Markus F. Neurath, Britta Siegmund. Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00517
|
| 33 |
Shiro Nakamura. Advances in Medical Treatment for Crohn's Disease: Focusing on Molecular Targeted Drugs. Nihon Daicho Komonbyo Gakkai Zasshi 2024; 77(10) doi: 10.3862/jcoloproctology.77.501
|
| 34 |
Tomasz Pytrus, Hubert Paweł Szyller, Gabriela Augustynowicz, Maria Lasocka, Sonia Watras, Katarzyna Akutko. Is Routine Monitoring of TNF-α Inhibitor Levels and Antibodies in Pediatric IBD Justified in the Era of Personalized Medicine. Journal of Clinical Medicine 2026; 15(11) doi: 10.3390/jcm15114098
|
| 35 |
Roberta Figueiroa Souza, Marcos Antônio Ferreira Caetano, Henrique Inhauser Riceti Magalhães, Patricia Castelucci. Study of tumor necrosis factor receptor in the inflammatory bowel disease. World Journal of Gastroenterology 2023; 29(18): 2733-2746 doi: 10.3748/wjg.v29.i18.2733
|
| 36 |
Liliana Lykowska-Szuber, Michal Walczak, Agnieszka Dobrowolska, Marzena Skrzypczak-Zielinska. Apoptosis and inflammatory genes variants in primary non-response to anti-TNF therapy in Crohn’s disease patients. European Journal of Gastroenterology & Hepatology 2023; 35(10) doi: 10.1097/MEG.0000000000002618
|
| 37 |
Seema Yadav, Narahari Narayan Palei, Subas Chandra Dinda, Arghya Kusum Dhar. Concepts in Pharmaceutical Biotechnology and Drug Development. Interdisciplinary Biotechnological Advances 2024; doi: 10.1007/978-981-97-1148-2_7
|
| 38 |
HoUng Kim, Rieke Alten, Luisa Avedano, Axel Dignass, Fernando Gomollón, Kay Greveson, Jonas Halfvarson, Peter M. Irving, Jørgen Jahnsen, Péter L. Lakatos, JongHyuk Lee, Souzi Makri, Ben Parker, Laurent Peyrin-Biroulet, Stefan Schreiber, Steven Simoens, Rene Westhovens, Silvio Danese, Ji Hoon Jeong. The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases. Drugs 2020; 80(2) doi: 10.1007/s40265-020-01256-5
|
| 39 |
Na Wu, Xinchong Du, Zhao Peng, Zetian Zhang, Lijun Cui, Duo Li, Rui Wang, Maoyuan Ma. Silencing of peroxiredoxin 1 expression ameliorates ulcerative colitis in a rat model. Journal of International Medical Research 2021; 49(3) doi: 10.1177/0300060520986313
|
| 40 |
Anna Kofla-Dłubacz, Tomasz Pytrus, Katarzyna Akutko, Patrycja Sputa-Grzegrzółka, Aleksandra Piotrowska, Piotr Dzięgiel. Etiology of IBD—Is It Still a Mystery?. International Journal of Molecular Sciences 2022; 23(20) doi: 10.3390/ijms232012445
|
| 41 |
Roberta Figueiroa Souza, Felipe Alexandre Machado, Marcos Antônio Ferreira Caetano, Caroline Bures De Paulo, Patricia Castelucci. Effect of Anti-TNF Monoclonal Antibody on Enteric Neurons and Enteric Glial Cells in Experimental Colitis. Digestive Diseases and Sciences 2025; 70(4) doi: 10.1007/s10620-025-08872-9
|
| 42 |
Giampaolo Morciano, Giulia Pellielo, Esther Densu Agyapong, Cristina Pellegrino, Simone Patergnani, Davide Franceschini, Konstantinos Koutsikos, Leonardo Rigon, Paolo Pinton, Alessandro Rimessi. The importance of mitochondria and mitochondrial calcium signaling in health and disease: an updated outlook on inflammation. Journal of Translational Medicine 2026; 24(1) doi: 10.1186/s12967-026-07783-1
|
| 43 |
Shima Hasanzadeh, Morgayn I. Read, Abigail R. Bland, Muhammed Majeed, Tannaz Jamialahmadi, Amirhossein Sahebkar. Curcumin: an inflammasome silencer. Pharmacological Research 2020; 159 doi: 10.1016/j.phrs.2020.104921
|
| 44 |
Qiuling Lin, Dingguo Zhang, Jian Zhang, Weixiang Luo, Zhenglei Xu, Jun Yao, Lisheng Wang. Identification of lncRNA DLEU2 as a potential diagnostic biomarker and anti-inflammatory target for ulcerative colitis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.991448
|
| 45 |
Francesca Penagini, Luisa Lonoce, Luisa Abbattista, Valentina Silvera, Giulia Rendo, Lucia Cococcioni, Dario Dilillo, Valeria Calcaterra, Gian Vincenzo Zuccotti. Dual biological therapy and small molecules in pediatric inflammatory bowel disease. Pharmacological Research 2023; 196 doi: 10.1016/j.phrs.2023.106935
|
| 46 |
Jill L. Kinzer, Troy A. Halseth, Jukyung Kang, Sang Yeop Kim, Preethi Kumaran, Michael Ford, Sergei Saveliev, St John Skilton, Anna Schwendeman. Physicochemical characterization and functionality comparison of Humira®(adalimumab), Remicade®(infliximab) and Simponi Aria®(golimumab). International Journal of Pharmaceutics 2023; 635 doi: 10.1016/j.ijpharm.2023.122646
|
| 47 |
Sonia Chadha. Exploring the interconnected pathobiology between Crohn's disease, ulcerative colitis and colorectal cancer through gene expression, pathway analysis and immune profiling. Human Gene 2025; 44 doi: 10.1016/j.humgen.2025.201404
|
| 48 |
Agata Michalak, Beata Kasztelan-Szczerbinska, Katarzyna Laskowska, Piotr Radwan, Marek Cybulski, Halina Cichoż-Lach. Efficacy of biological treatment in inflammatory bowel disease – a single-center experience. Polish Journal of Public Health 2019; 129(3) doi: 10.2478/pjph-2019-0024
|
| 49 |
Joel V. Chua, John W. Baddley. Infectious Complications in Biologic and Targeted Therapies. 2022; doi: 10.1007/978-3-031-11363-5_5
|
| 50 |
Ladan Agharokh, Katherine Mamola, Andrew G. Yu, Annette L. Medina, Bhaskar Gurram, Julie Fuller, Jason Y. Park, Weina Chen, Veena Rajaram, Matthew R. Hammer, Jeff L. Waugh. Cachexia, chorea, and pain in chronic nonbacterial osteitis and inflammatory bowel disease: a case report. Journal of Medical Case Reports 2023; 17(1) doi: 10.1186/s13256-023-03894-1
|
| 51 |
Han Huang, Chenxiao Gan, Yan Cai, Lingkang Wu. Immunological relationship between Helicobacter pylori and anti-tumor necrosis factor α agents in inflammatory bowel disease. Central European Journal of Immunology 2024; 49(1) doi: 10.5114/ceji.2024.136376
|
| 52 |
Sudha B. Singh, Cody A. Braun, Amanda Carroll-Portillo, Cristina N. Coffman, Henry C. Lin. Sulfate-Reducing Bacteria Induce Pro-Inflammatory TNF-α and iNOS via PI3K/Akt Pathway in a TLR 2-Dependent Manner. Microorganisms 2024; 12(9) doi: 10.3390/microorganisms12091833
|
| 53 |
Vojtech Dotlacil, Stepan Coufal, Tereza Lerchova, Kristyna Zarubova, Barbora Kucerova, Helena Tlaskalova-Hogenova, Miloslav Kverka, Richard Skaba, Jiri Bronsky, Ondrej Hradsky, Michal Rygl. Intestinal tissue levels of anti-TNF alpha, antibodies, and cytokines in paediatric Crohn disease. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-024-83858-7
|
| 54 |
Yuki Ozato, Tomoaki Hara, Sikun Meng, Hiromichi Sato, Shotaro Tatekawa, Mamoru Uemura, Takeshi Yabumoto, Shizuka Uchida, Kazuhiko Ogawa, Yuichiro Doki, Hidetoshi Eguchi, Hideshi Ishii. RNA methylation in inflammatory bowel disease. Cancer Science 2024; 115(3) doi: 10.1111/cas.16048
|
| 55 |
Raja Atreya, Markus F Neurath. IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality. Journal of Crohn's and Colitis 2022; 16(Supplement_2) doi: 10.1093/ecco-jcc/jjac007
|
| 56 |
Federica Crispino, Mauro Grova, Erica Maria Bruno, Noemi Monachino, Giuseppe Rizzo, Angelo Casà, Sara Renna, Fabio Salvatore Macaluso, Ambrogio Orlando. Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets. Drugs 2022; 82(11) doi: 10.1007/s40265-022-01750-y
|
| 57 |
Asma Boumaza, Soraya Mezouar, Matthieu Bardou, Didier Raoult, Jean-Louis Mège, Benoit Desnues. Tumor Necrosis Factor Inhibitors Exacerbate Whipple’s Disease by Reprogramming Macrophage and Inducing Apoptosis. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.667357
|
| 58 |
Ling Zhang, Yihang Zhang, Jihong Pan. Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs. Intractable & Rare Diseases Research 2021; 10(3) doi: 10.5582/irdr.2021.01022
|
| 59 |
Jinshun Zhu, Huan Yu, Longzhi Xie, Dujuan Shuai, Zhixian Huang, Yufei Chen, Chao Ni, Chang Jia, Xing Rong, Lifang Zhang, Maoping Chu. A novel format of TNF-α binding affibody molecule ameliorate coronary artery endothelial injury in a mouse model of Kawasaki disease. International Journal of Biological Macromolecules 2024; 281 doi: 10.1016/j.ijbiomac.2024.136255
|
| 60 |
Yue Zeng, Xingyu Liu, Qing Yi, Gan Qiao, Lulu Wang, Li Chen, Ling Fan, Yao Li, Lingjing Duan, Liqiang Huang, Qian Zhuang, Yejiang Zhou, Yuxia Xiong. Free total rhubarb anthraquinones protect intestinal mucosal barrier of SAP rats via inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway. Journal of Ethnopharmacology 2024; 326 doi: 10.1016/j.jep.2024.117873
|
| 61 |
Yaoyao Du, Lan Rong, Yuanhua Cong, Lan Shen, Ning Zhang, Bing Wang. Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease. Expert Opinion on Therapeutic Targets 2021; 25(3) doi: 10.1080/14728222.2021.1901079
|
| 62 |
Talal S. Alharbi, Ziyad S. Alshammari, Ziyad N. Alanzi, Fahad Althobaiti, Mohammed A. F. Elewa, Khalid S. Hashem, Mohammed M. H. Al-Gayyar. Therapeutic effects of genistein in experimentally induced ulcerative colitis in rats via affecting mitochondrial biogenesis. Molecular and Cellular Biochemistry 2024; 479(2) doi: 10.1007/s11010-023-04746-8
|
| 63 |
Dan Pu, Zhe Zhang, Baisui Feng. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.906419
|
| 64 |
Tamir Baram, Nino Oren, Nofar Erlichman, Tsipi Meshel, Adit Ben-Baruch. Inflammation-Driven Regulation of PD-L1 and PD-L2, and Their Cross-Interactions with Protective Soluble TNFα Receptors in Human Triple-Negative Breast Cancer. Cancers 2022; 14(14) doi: 10.3390/cancers14143513
|
| 65 |
Florence Hoogewoud, Laura Kowalczuk, Elodie Bousquet, Antoine Brézin, Elodie Touchard, Ronald Buggage, Thierry Bordet, Francine Behar-Cohen. Les anti-TNF-α pour le traitement des uvéites non infectieuses. médecine/sciences 2020; 36(10) doi: 10.1051/medsci/2020160
|
| 66 |
Meng‐Tzu Weng, Chia‐Yueh Hsiung, Shu‐Chen Wei, Yunching Chen. Nanotechnology for Targeted Inflammatory Bowel Disease Therapy: Challenges and Opportunities. WIREs Nanomedicine and Nanobiotechnology 2024; 16(5) doi: 10.1002/wnan.1999
|
| 67 |
Rosanne W Meijboom, Liese Barbier, Louise C Druedahl, Kati Sarnola, Hanna M Tolonen, Helga Gardarsdottir, Toine C G Egberts, Thijs J Giezen. Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance. Expert Opinion on Biological Therapy 2023; 23(8) doi: 10.1080/14712598.2023.2189008
|
| 68 |
Wenqing Yu, Yumin Zhao, Yuwei Zhang, Yaqian Li, Yiren Yang, Junying Wang, Hui Wang, Hua Shi, Chuqiao Xiao, Mouming Zhao, Jie Gao. Gut microbial metabolites-mediated modulation of colitis in mice by three geographically varied dietary patterns. Food Science and Human Wellness 2025; 14(12) doi: 10.26599/FSHW.2024.9250420
|
| 69 |
Francesca Burlo, Serena Pastore, Gabriele Stocco, Paolo Dalla Zuanna, Debora Curci, Tomoyuki Mizuno, Kei Irie, Andrea Taddio, Alberto Tommasini. Give weekly adalimumab a chance before discontinuing it: a retrospective clinical and pharmacokinetic analysis in pediatric rheumatology. Arthritis Research & Therapy 2025; 27(1) doi: 10.1186/s13075-025-03688-4
|
| 70 |
Patricia Mae Garcia, Jeff Moore, David Kahan, Mee Young Hong. Effects of Vitamin D Supplementation on Inflammation, Colonic Cell Kinetics, and Microbiota in Colitis: A Review. Molecules 2020; 25(10) doi: 10.3390/molecules25102300
|
| 71 |
Shyi-Jou Chen, Gu-Jiun Lin, Jing-Wun Chen, Kai-Chen Wang, Chiung-Hsi Tien, Chih-Fen Hu, Chia-Ning Chang, Wan-Fu Hsu, Hueng-Chuen Fan, Huey-Kang Sytwu. Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis. International Journal of Molecular Sciences 2019; 20(6) doi: 10.3390/ijms20061332
|
| 72 |
Barbara Ruder, Raja Atreya, Christoph Becker. Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases. International Journal of Molecular Sciences 2019; 20(8) doi: 10.3390/ijms20081887
|
| 73 |
H.B. Costa-Filho, T.M.A.L. Sales, S.M. Paula, L.A.D. Nicolau, M.L. Queiroga, A. Havt, P.M.G. Soares, A.L.R. Barbosa, M.H.L.P. Souza. Role of cyclooxygenases 1 and 2 in the maintenance of colonic mucosal integrity in an experimental colitis model. Brazilian Journal of Medical and Biological Research 2023; 56 doi: 10.1590/1414-431x2023e12946
|
| 74 |
J.W. Baddley, F. Cantini, D. Goletti, J.J. Gómez-Reino, E. Mylonakis, R. San-Juan, M. Fernández-Ruiz, J. Torre-Cisneros. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents). Clinical Microbiology and Infection 2018; 24 doi: 10.1016/j.cmi.2017.12.025
|
| 75 |
Sung-Eun Kim, Il-Gyu Ko, Jun-Jang Jin, Lakkyong Hwang, Chang-Ju Kim, Sang-Hoon Kim, Jin-Hee Han, Jung Won Jeon, Anna Chiarini. Polydeoxyribonucleotide Exerts Therapeutic Effect by Increasing VEGF and Inhibiting Inflammatory Cytokines in Ischemic Colitis Rats. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/2169083
|
| 76 |
Chuan Zhang, Huiping Zhu, Hui Jie, Hengyue Ding, Hongwen Sun. Arbutin ameliorated ulcerative colitis of mice induced by dextran sodium sulfate (DSS). Bioengineered 2021; 12(2) doi: 10.1080/21655979.2021.2005746
|
| 77 |
E. A. Belousova, I. G. Kozlov, D. I. Abdulganieva, O. P. Alexeeva, I. V. Gubonina, A. A. Lishchinskaya, L. V. Tarasova, E. Yu. Chashkova, M. V. Shapina, O. S. Shifrin, O. B. Shchukina. Immunological aspects of determination of an adequate biological treatment sequence for inflammatory bowel diseases: the expert board statement (St. Petersburg, May 22, 2021). Almanac of Clinical Medicine 2021; 49(7) doi: 10.18786/2072-0505-2021-49-060
|
| 78 |
Shinya Toriumi, Yousuke Kurihara, Komei Shimokawa, Arihito Tanaka, Norito Araki, Osamu Kawai, Yasoo Sugiura, Yoshihiro Uesawa. Disproportionality Analysis and Timing of Drug-Associated Guillain–Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database. Pharmaceuticals 2026; 19(5) doi: 10.3390/ph19050688
|
| 79 |
Annalisa Di Rienzo, Lisa Marinelli, Marilisa Pia Dimmito, Eleonora Chiara Toto, Antonio Di Stefano, Ivana Cacciatore. Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems. Pharmaceutics 2024; 16(9) doi: 10.3390/pharmaceutics16091185
|
| 80 |
M. Eugenia Delgado, Thomas Brunner. The many faces of tumor necrosis factor signaling in the intestinal epithelium. Genes & Immunity 2019; 20(8) doi: 10.1038/s41435-019-0057-0
|
| 81 |
Vu Q. Nguyen, Kristin Eden, Holly A. Morrison, Megan B. Sammons, Kristin K. Knight, Siena Sorrentino, Rebecca M. Brock, Douglas J. Grider, Irving C. Allen, Dario Sorrentino. Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.655887
|
| 82 |
Marwa Ben-Khemis, Dan Liu, Coralie Pintard, Zhuoyao Song, Margarita Hurtado-Nedelec, Jean-Claude Marie, Jamel El-Benna, Pham My-Chan Dang. TNFα counteracts interleukin-10 anti-inflammatory pathway through the NOX2-Lyn-SHP-1 axis in human monocytes. Redox Biology 2023; 67 doi: 10.1016/j.redox.2023.102898
|
| 83 |
Xiaolin Ye, Jie Wu, Jing Li, Hongyu Wang, Hon W. Koon. Anterior Gradient Protein 2 Promotes Mucosal Repair in Pediatric Ulcerative Colitis. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/6483860
|
| 84 |
María Chaparro, Adrià Aterido, Iván Guerra, Marisa Iborra, Jose Luis Cabriada, Luis Bujanda, Carlos Taxonera, Valle García-Sánchez, Ignacio Marín-Jiménez, Manuel Barreiro-de Acosta, Isabel Vera, Maria Dolores Martín-Arranz, Borja Hernández-Breijo, Francisco Mesonero, Laura Sempere, Fernando Gomollón, Joaquín Hinojosa, Fernando Bermejo, Belén Beltrán, Ainhoa Rodríguez-Pescador, Jesús María Banales, David Olivares, Patricia Aguilar-Melero, Luis Menchén, Rocío Ferreiro-Iglesias, Isabel Blazquez Gómez, Beatriz Benitez García, Luis G Guijarro, Alicia C Marin, David Bernardo, Sara Marsal, Antonio Julia, Javier P Gisbert. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819867848
|
| 85 |
Manuel Sutter, Petr Hruz, Jan Hendrik Niess. High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease Patients. Inflammatory Intestinal Diseases 2021; 6(3) doi: 10.1159/000518264
|
| 86 |
Iuliana Samoilă, Sorina Dinescu, Marieta Costache. Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development—A Focus on Ulcerative Colitis. Cells 2020; 9(7) doi: 10.3390/cells9071647
|
| 87 |
Markus Ries, Brice Moulari, Maryam A. Shetab Boushehri, Mohamed Ehab Ali, Daniel Molnar, Arnaud Béduneau, Yann Pellequer, Alf Lamprecht. Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting. Pharmaceutics 2022; 14(2) doi: 10.3390/pharmaceutics14020352
|
| 88 |
Hung Hiep Huynh, Naoki Morita, Toshihiro Sakamoto, Takuya Katayama, Takuya Miyakawa, Masaru Tanokura, Yasunori Chiba, Reiko Shinkura, Jun-ichi Maruyama. Functional production of human antibody by the filamentous fungus Aspergillus oryzae. Fungal Biology and Biotechnology 2020; 7(1) doi: 10.1186/s40694-020-00098-w
|
| 89 |
Mai Murakami, Michio Onizawa, Naoto Abe, Tomoaki Mochimaru, Chikako Saito, Rie Hikichi, Takefumi Uemura, Masayuki Sekimata, Hiromasa Ohira. N-glycosylation negatively regulates the expression of tumor necrosis factor (TNF) in mouse macrophage. Biochemical and Biophysical Research Communications 2024; 737 doi: 10.1016/j.bbrc.2024.150897
|
| 90 |
Shijin Wu, Yuyang Zhou. Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review. Therapeutic Advances in Psychopharmacology 2024; 14 doi: 10.1177/20451253241227772
|
| 91 |
Emanual Maverakis, Angelo V. Marzano, Stephanie T. Le, Jeffrey P. Callen, Marie-Charlotte Brüggen, Emmanuella Guenova, Joachim Dissemond, Kanade Shinkai, Sinéad M. Langan. Pyoderma gangrenosum. Nature Reviews Disease Primers 2020; 6(1) doi: 10.1038/s41572-020-0213-x
|
| 92 |
Linor Rubinstein-Achiasaf, Dina Morein, Hagar Ben-Yaakov, Yulia Liubomirski, Tsipi Meshel, Eti Elbaz, Orly Dorot, Edward Pichinuk, Michael Gershovits, Miguel Weil, Adit Ben-Baruch. Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells. Cancers 2021; 13(6) doi: 10.3390/cancers13061472
|
| 93 |
Barrett O. Attarha, Radhika Sharma, Vinit H. Majmudar, Lee Shapiro, Andrew Flint, Peter Ghali. GI Diseases Associated with Rheumatological and Vasculitic Conditions. Clinical Gastroenterology 2025; doi: 10.1007/978-3-032-07868-1_20
|
| 94 |
Zhaofeng Tan, Haibin Xue, Yuli Sun, Chuanlong Zhang, Yonglei Song, Yuanfu Qi. The Role of Tumor Inflammatory Microenvironment in Lung Cancer. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.688625
|
| 95 |
Raffaella Franca, Debora Curci, Marianna Lucafò, Giuliana Decorti, Gabriele Stocco. Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 2019; 15(7) doi: 10.1080/17425255.2019.1630378
|
| 96 |
Laurence Chapuy, Marwa Bsat, Siranush Sarkizova, Manuel Rubio, Amélie Therrien, Evelyne Wassef, Mickael Bouin, Katarzina Orlicka, Audrey Weber, Nir Hacohen, Alexandra-Chloé Villani, Marika Sarfati. Two distinct colonic CD14+ subsets characterized by single-cell RNA profiling in Crohn's disease. Mucosal Immunology 2019; 12(3) doi: 10.1038/s41385-018-0126-0
|
| 97 |
Tamara Ortiz, Federico Argüelles-Arias, Matilde Illanes, Josefa-María García-Montes, Elena Talero, Laura Macías-García, Ana Alcudia, Victoria Vázquez-Román, Virginia Motilva, Manuel De-Miguel. Polyphenolic Maqui Extract as a Potential Nutraceutical to Treat TNBS-Induced Crohn’s Disease by the Regulation of Antioxidant and Anti-Inflammatory Pathways. Nutrients 2020; 12(6) doi: 10.3390/nu12061752
|
| 98 |
Beate Beyer, Nicole Walch, Alois Jungbauer, Nico Lingg. How Similar Is Biosimilar? A Comparison of Infliximab Therapeutics in Regard to Charge Variant Profile and Antigen Binding Affinity. Biotechnology Journal 2019; 14(4) doi: 10.1002/biot.201800340
|
| 99 |
Michal Walczak, Liliana Lykowska-Szuber, Marianna Plucinska, Kamila Stawczyk-Eder, Oliwia Zakerska-Banaszak, Piotr Eder, Iwona Krela-Kazmierczak, Michal Michalak, Marek Zywicki, Wojciech M. Karlowski, Marlena Szalata, Agnieszka Dobrowolska, Ryszard Slomski, Marzena Skrzypczak-Zielinska. Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01207
|
| 100 |
Lamiaa A. Hassan, Medhat A. Al‐Ghobashy, Samah S. Abbas. Evaluation of the pattern and kinetics of degradation of adalimumab using a stability‐indicating orthogonal testing protocol. Biomedical Chromatography 2019; 33(12) doi: 10.1002/bmc.4676
|
| 101 |
Meenu Wadhwa, Chris Bird, Eleanor Atkinson, Isabelle Cludts, Peter Rigsby. The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.636420
|
| 102 |
Joanna Grudzinska-Goebel, Karin Benstein, Karien Bloem, Kyra J. Cowan, Boris Gorovits, Maria Jadhav, Melody Janssen, Vibha Jawa, Andrea Kiessling, Daniel Kramer, Arno Kromminga, Marcel van der Linden, Susana Liu, Gregor P. Lotz, Linlin Luo, Mantas Malisauskas, Céline Marban-Doran, Daniel T. Mytych, Elisa Oquendo Cifuentes, Susanne Pippig, Sandra Ribes, Myrthe Rouwette, Weiping Shao, Sophie Tourdot, Karin Nana Weldingh, Veerle Snoeck. Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1581153
|
| 103 |
Siyi Ni, Yingchao Liu, Jihong Zhong, Yan Shen. Identification and immunoinfiltration analysis of key genes in ulcerative colitis using WGCNA. PeerJ 2024; 12 doi: 10.7717/peerj.16921
|
| 104 |
Marcella Gabrielle Mendes Machado, Cauê Benito Scarim, Cleverton Roberto de Andrade, Jean Leandro dos Santos, Chung Man Chin. Synthesis and anti-inflammatory intestinal activity of new glucocorticoid derivatives. Medicinal Chemistry Research 2020; 29(2) doi: 10.1007/s00044-019-02474-7
|
| 105 |
Walter Reinisch, Stanley Cohen, Monica Ramchandani, Majed Khraishi, Jennifer Liu, Vincent Chow, Janet Franklin, Jean-Frederic Colombel. A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar. Advances in Therapy 2022; 39(1) doi: 10.1007/s12325-021-01944-y
|
| 106 |
Boushra Abou Hjeily, Briana Candace Nevaneeth, Włodzimierz Samborski, Zoltán Szekanecz, Bogna Grygiel-Górniak. Inflammatory Pathways to Carcinogenesis: Deciphering the Rheumatoid Arthritis–Lung Cancer Connection. Cancers 2025; 17(8) doi: 10.3390/cancers17081330
|
| 107 |
Stephan Blüml. Biologika und „small molecules“ bei der rheumatoiden Arthritis. Zeitschrift für Rheumatologie 2020; 79(3) doi: 10.1007/s00393-020-00766-7
|
| 108 |
Olivier Lortholary, Mario Fernandez-Ruiz, John W Baddley, Oriol Manuel, Xavier Mariette, Kevin L Winthrop. Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020. Annals of the Rheumatic Diseases 2020; 79(12) doi: 10.1136/annrheumdis-2020-217092
|
| 109 |
Ramsey Saleem, Greg Cantin, Mats Wikström, Glen Bolton, Scott Kuhns, Helen J. McBride, Jennifer Liu. Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product. Pharmaceutical Research 2020; 37(6) doi: 10.1007/s11095-020-02816-w
|
| 110 |
Alexandra S. Rasiuk, Scott R. Walsh, Lily Chan, Alicia M. Viloria-Petit, Sarah K. Wootton, Khalil Karimi, Byram W. Bridle. The Role of Type I Interferon Signaling in Regulating Cytokine Production and Cell Survival in Bone Marrow-Derived Macrophages. Viral Immunology 2021; 34(7) doi: 10.1089/vim.2020.0308
|
| 111 |
E Antiga, R Maglie, W Volpi, B Bianchi, E Berti, A V Marzano, M Caproni. T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum. Clinical and Experimental Immunology 2017; 189(3) doi: 10.1111/cei.12989
|
| 112 |
Ty M. Mitchell, Nicole C. Burdick Sanchez, Jeff A. Carroll, Paul R. Broadway, Jerrad F. Legako, Brooke M. Bowen, Amy L. Petry. Prenatal lipopolysaccharide stimulation modulates gastrointestinal immunity and oxidative status in weaned pigs. American Journal of Physiology-Gastrointestinal and Liver Physiology 2025; 328(3) doi: 10.1152/ajpgi.00268.2024
|
| 113 |
Junsuke Uwada, Takashi Yazawa, Md Tariqul Islam, Md Rafiqul Islam Khan, Susanne M. Krug, Michael Fromm, Shin-ichiro Karaki, Yuichi Suzuki, Atsukazu Kuwahara, Hatsumi Yoshiki, Kiyonao Sada, Ikunobu Muramatsu, Takanobu Taniguchi. Activation of muscarinic receptors prevents TNF-α-mediated intestinal epithelial barrier disruption through p38 MAPK. Cellular Signalling 2017; 35 doi: 10.1016/j.cellsig.2017.04.007
|
| 114 |
Shengjie Ma, Jiaxin Zhang, Heshi Liu, Shuang Li, Quan Wang. The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.896591
|
| 115 |
Jerry Z. Xu, Ramesh Kumar, Haoli Gong, Luyao Liu, Nicole Ramos-Solis, Yujing Li, Wilbert A. Derbigny, Craig R. Roy. Toll-Like Receptor 3 Deficiency Leads to Altered Immune Responses to Chlamydia trachomatis Infection in Human Oviduct Epithelial Cells. Infection and Immunity 2019; 87(10) doi: 10.1128/IAI.00483-19
|
| 116 |
Baohai Liu, Xuehua Piao, Lianyi Guo, Guijun Wang, Weihua Sun, Leming Gao, Xuefeng Zheng, Yanli Fang, Steve Harakeh. A New Chinese Medicine Intestine Formula Greatly Improves the Effect of Aminosalicylate on Ulcerative Colitis. Evidence-Based Complementary and Alternative Medicine 2017; 2017(1) doi: 10.1155/2017/7323129
|
| 117 |
Cecil Nick. Optimizing development of anti-TNFα biosimilars based on 10 years’ experience. Exploration of Musculoskeletal Diseases 2025; doi: 10.37349/emd.2025.100782
|
| 118 |
Katia Aquilano, Veronica Ceci, Angelo Gismondi, Susanna De Stefano, Federico Iacovelli, Raffaella Faraonio, Gabriele Di Marco, Noemi Poerio, Antonella Minutolo, Giuseppina Minopoli, Antonia Marcone, Maurizio Fraziano, Flavia Tortolici, Simona Sennato, Stefano Casciardi, Marina Potestà, Roberta Bernardini, Maurizio Mattei, Mattia Falconi, Carla Montesano, Stefano Rufini, Antonella Canini, Daniele Lettieri-Barbato. Adipocyte metabolism is improved by TNF receptor-targeting small RNAs identified from dried nuts. Communications Biology 2019; 2(1) doi: 10.1038/s42003-019-0563-7
|
| 119 |
Songmao Zheng, Jin Niu, Brian Geist, Damien Fink, Zhenhua Xu, Honghui Zhou, Weirong Wang. A minimal physiologically based pharmacokinetic model to characterize colon TNF suppression and treatment effects of an anti-TNF monoclonal antibody in a mouse inflammatory bowel disease model. mAbs 2020; 12(1) doi: 10.1080/19420862.2020.1813962
|
| 120 |
Rachel K. Lim, Dina A. Fisher, Stephen K. Field. Tuberculosis. Integrated Science 2023; 11 doi: 10.1007/978-3-031-15955-8_32
|
| 121 |
Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi. Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study. Intestinal Research 2021; 19(4) doi: 10.5217/ir.2020.00033
|
| 122 |
Chang-Cyuan Chen, Yu-An Lin, Kuan-Ting Liu, Chun-Yao Huang, Chun-Ming Shih, Yuan-Ti Lee, Jun-Liang Pan, Ai-Wei Lee. Navigating SARS-CoV-2-related immunopathology in Crohn’s disease: from molecular mechanisms to therapeutic challenges. Virology Journal 2024; 21(1) doi: 10.1186/s12985-024-02529-1
|
| 123 |
Maria S Simon, Gara Arteaga-Henríquez, Ahmed Fouad Algendy, Timo Siepmann, Ben MW Illigens. Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses. Neuropsychiatric Disease and Treatment 2023; doi: 10.2147/NDT.S385117
|
| 124 |
J. Scott Crowe, Kevin J. Roberts, Timothy M. Carlton, Luana Maggiore, Marion F. Cubitt, Simon Clare, Katherine Harcourt, Jill Reckless, Thomas T. MacDonald, Keith P. Ray, Anna Vossenkämper, Michael R. West. Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-23277-7
|
| 125 |
Gregor Jezernik, Mario Gorenjak, Uroš Potočnik. MIF Variant rs755622 Is Associated with Severe Crohn’s Disease and Better Response to Anti-TNF Adalimumab Therapy. Genes 2023; 14(2) doi: 10.3390/genes14020452
|
| 126 |
Tamir Baram, Linor Rubinstein-Achiasaf, Hagar Ben-Yaakov, Adit Ben-Baruch. Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.614468
|
| 127 |
Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli, Khazna Alotaibi, Abdullah Alsahli, Hussain Mohammad, Preethi Cherian, Irina Al-Khairi, Thangavel Alphonse Thanaraj, Arshad Channanath, Hamad Ali, Mohamed Abu-Farha, Jehad Abubaker, Fahd Al-Mulla. Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies. Vaccines 2021; 9(12) doi: 10.3390/vaccines9121471
|
| 128 |
Hong‐Gang Wang, Min‐Na Zhang, Xin Wen, Le He, Meng‐Hui Zhang, Jia‐Ling Zhang, Xiao‐Zhong Yang. Cepharanthine ameliorates dextran sulphate sodium‐induced colitis through modulating gut microbiota. Microbial Biotechnology 2022; 15(8) doi: 10.1111/1751-7915.14059
|
| 129 |
Ziwen Yuan, Lihong Yang, Xiaosong Zhang, Peng Ji, Yongli Hua, Yanming Wei. Huang-Lian-Jie-Du Decoction Ameliorates Acute Ulcerative Colitis in Mice via Regulating NF-κB and Nrf2 Signaling Pathways and Enhancing Intestinal Barrier Function. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.01354
|
| 130 |
Xue Liu, Lin-Xiao Pan, Jia-Xian Pei, Tian Pu, Hong-Tao Wen, Ye Zhao. Role of serological biomarkers in evaluating and predicting endoscopic activity in inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(18): 104206 doi: 10.3748/wjg.v31.i18.104206
Abstract(411) |
Core Tip(392) |
Full Article(HTML)(1738)
|
Full Article (PDF)-1297K(164)
|
Full Article with Cover (PDF)-1562K(151)
|
Full Article (XML)-76K(85)
|
Audio-1325K(16)
|
Peer-Review Report-241K(98)
|
Answering Reviewers-240K(78)
|
Supplementary Material-499K(95)
|
Times Cited (4)
|
Total Visits (2743)
|
Open
|
| 131 |
Cong-Qiu Chu. Blocking tumor necrosis factor paved the way for targeted therapeutics in inflammatory diseases. Chinese Medical Journal 2021; 134(21) doi: 10.1097/CM9.0000000000001846
|
| 132 |
Anna Kofla-Dłubacz, Katarzyna Akutko, Elżbieta Krzesiek, Tatiana Jamer, Joanna Braksator, Paula Grębska, Tomasz Pytrus, Andrzej Stawarski. Selective Forms of Therapy in the Treatment of Inflammatory Bowel Diseases. Journal of Clinical Medicine 2022; 11(4) doi: 10.3390/jcm11040994
|
| 133 |
Renata Curciarello, Toni Sobande, Samantha Jones, Paolo Giuffrida, Antonio Di Sabatino, Guillermo H Docena, Thomas T MacDonald, Klaartje Kok. <p>Human Neutrophil Elastase Proteolytic Activity in Ulcerative Colitis Favors the Loss of Function of Therapeutic Monoclonal Antibodies</p>. Journal of Inflammation Research 2020; doi: 10.2147/JIR.S234710
|
| 134 |
Hu Zhao, Taohui Ding, Yanglin Chen, Wenbin Yang, Jun Rao, Dan Liu, Bo Yi. Arecoline aggravates acute ulcerative colitis in mice by affecting intestinal microbiota and serum metabolites. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1197922
|
| 135 |
Adam Saleh, Usman Ansari, Shaadi Abughazaleh, Kerri Glassner, Bincy P Abraham. Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician. Biologics: Targets and Therapy 2022; doi: 10.2147/BTT.S335697
|
| 136 |
Laura Clua‐Ferré, Roger Suau, Irene Vañó‐Segarra, Iris Ginés, Carolina Serena, Josep Manyé. Therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles: A focus on inflammatory bowel disease. Clinical and Translational Medicine 2024; 14(11) doi: 10.1002/ctm2.70075
|
| 137 |
Carl L. Manthey, Beverley A. Moore, Yanqing Chen, Matthew J. Loza, Xiang Yao, Hao Liu, Stanley M. Belkowski, Holly Raymond-Parks, Paul J. Dunford, Francisco Leon, Jennifer E. Towne, Scott E. Plevy, Jörn Karhausen. The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis. PLOS ONE 2019; 14(11) doi: 10.1371/journal.pone.0223918
|
| 138 |
Irene Marafini, Silvia Sedda, Vincenzo Dinallo, Giovanni Monteleone. Inflammatory cytokines: from discoveries to therapies in IBD. Expert Opinion on Biological Therapy 2019; 19(11) doi: 10.1080/14712598.2019.1652267
|
| 139 |
Alexander V Blagov, Marina D Sazonova, Anastasia I Ryzhkova, Vasily P Karagodin, Mikhail A Popov, Egor Yu Budnikov, Alessio L Ravani, Alexander N Orekhov, Margarita A Sazonova, Yuri V Arkhipenko. Analysis of the use of monoclonal antibodies in the treatment of Crohn’s disease. Antibody Therapeutics 2026; 9(2) doi: 10.1093/abt/tbag006
|
| 140 |
Ramasatyaveni Geesala, Willow Schanz, Mikayla Biggs, Garima Dixit, Joseph Skurski, Prajwal Gurung, David K Meyerholz, David Elliott, Priya D Issuree, Thorsten Maretzky. Loss of RHBDF2 results in an early-onset spontaneous murine colitis. Journal of Leukocyte Biology 2019; 105(4) doi: 10.1002/JLB.4A0718-283RR
|
| 141 |
Sabrina Nicolò, Ilaria Faggiani, Carmela Errico, Ferdinando D’Amico, Tommaso Lorenzo Parigi, Silvio Danese, Federica Ungaro. Translational characterization of immune pathways in inflammatory bowel disease: insights for targeted treatments. Expert Review of Clinical Immunology 2025; 21(1) doi: 10.1080/1744666X.2024.2400300
|
| 142 |
Jill Coghlan, Hongliang He, Anna S. Schwendeman. Overview of Humira® Biosimilars: Current European Landscape and Future Implications. Journal of Pharmaceutical Sciences 2021; 110(4) doi: 10.1016/j.xphs.2021.02.003
|
| 143 |
Silvia L Cruz-Martín-del-Campo, Claudia González-Espinosa, Ana Karen Ruiz-Quiñonez, César Javier Carranza-Aguilar. Tipos de muerte celular y sus implicaciones clínicas. El Residente 2020; 15(3) doi: 10.35366/95960
|
| 144 |
Xinxin Luo, Eduardo J. Villablanca. Type 2 immunity in intestinal homeostasis and inflammatory bowel disease. Biochemical Society Transactions 2021; 49(5) doi: 10.1042/BST20210535
|
| 145 |
Simona Adesso, Giuseppina Autore, Andrea Quaroni, Ada Popolo, Lorella Severino, Stefania Marzocco. The Food Contaminants Nivalenol and Deoxynivalenol Induce Inflammation in Intestinal Epithelial Cells by Regulating Reactive Oxygen Species Release. Nutrients 2017; 9(12) doi: 10.3390/nu9121343
|
| 146 |
Parsa S. Haque, Neeraj Kapur, Terrence A. Barrett, Arianne L. Theiss. Mitochondrial function and gastrointestinal diseases. Nature Reviews Gastroenterology & Hepatology 2024; 21(8) doi: 10.1038/s41575-024-00931-2
|
| 147 |
Xianping Li, Mingzhe Wang, Chang Liu, Yuchun Xiao, Mengde Li, Chengjun Ban, Yuanming Huang, Miao Cheng, Liqiong Song, Guoxing Liu, Shan Lu, Chengxiang Wang, Zhihong Ren. Qingfeiyin Decoction Inhibits H1N1 Virus Infection via Modulation of Gut Microbiota and Inflammatory Pathways in a Murine Model. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.874068
|
| 148 |
Elizabeth C. Rose, Jeremy M. Simon, Ismael Gomez-Martinez, Scott T. Magness, Jack Odle, Anthony T. Blikslager, Amanda L. Ziegler. Single-cell transcriptomics predict novel potential regulators of acute epithelial restitution in the ischemia-injured intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology 2025; 328(3) doi: 10.1152/ajpgi.00194.2024
|
| 149 |
Leticia A. Shea, Jamshaid S. Ahmed. Highly effective treatment options for rheumatoid arthritis afforded by the availability of biosimilars. Exploration of Musculoskeletal Diseases 2025; doi: 10.37349/emd.2025.100787
|
| 150 |
Rui Han, Li Wang, Zhengang Zhao, Lijun You, Sandra Pedisić, Viktoryia Kulikouskaya, Zhiqi Lin. Polysaccharide from Gracilaria Lemaneiformis prevents colitis in Balb/c mice via enhancing intestinal barrier function and attenuating intestinal inflammation. Food Hydrocolloids 2020; 109 doi: 10.1016/j.foodhyd.2020.106048
|
| 151 |
Yulia Liubomirski, Adit Ben-Baruch. Notch-Inflammation Networks in Regulation of Breast Cancer Progression. Cells 2020; 9(7) doi: 10.3390/cells9071576
|
| 152 |
Mikayla R. King, Roslyn A. Kemp, Safina Gadeock. Type I interferons in inflammatory bowel diseases: balancing barrier integrity, repair and inflammation in the intestinal epithelium. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1713424
|
| 153 |
Sophie Steeland, Claude Libert, Roosmarijn E. Vandenbroucke. A New Venue of TNF Targeting. International Journal of Molecular Sciences 2018; 19(5) doi: 10.3390/ijms19051442
|
| 154 |
Ahmed Adekunle Owolabi, Iqra Qazi, Nadia Ahmed, Mariam Amro Alsayed, Muhammad Abu Zar, Taimour Rashid Choudhry, Dhanushan Gnanendran, Aqsa Khan, Amrutha Amrutha, Huzaifa Ahmad Cheema, Asma’a Munasar Ali Alsubari, Essam Rashad, Adnan Bhat, Faryal Altaf, Prasun K. Jalal. TNF antagonists withdrawal is not advised in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis of randomized controlled trials. International Journal of Colorectal Disease 2025; 40(1) doi: 10.1007/s00384-025-05047-w
|
| 155 |
Jae Jun Park. Mechanism-based Drug Therapy of Inflammatory Bowel Disease With Special Reference to Rheumatic Disease. Journal of Rheumatic Diseases 2020; 27(3) doi: 10.4078/jrd.2020.27.3.128
|
| 156 |
Jonathan L. Digby-Bell, Raja Atreya, Giovanni Monteleone, Nick Powell. Interrogating host immunity to predict treatment response in inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology 2020; 17(1) doi: 10.1038/s41575-019-0228-5
|
| 157 |
Alexandra Garten Schmitt, Thomas Erwes, Lisa M. Chirch. Inflammatory Bowel Disease. Clinical Gastroenterology 2021; doi: 10.1007/978-3-030-81780-0_6
|
| 158 |
Robert Pietschner, Timo Rath, Markus F. Neurath, Raja Atreya. Current and Emerging Targeted Therapies for Ulcerative Colitis. Visceral Medicine 2023; 39(2) doi: 10.1159/000530983
|
| 159 |
Junsuke Uwada, Hitomi Nakazawa, Ikunobu Muramatsu, Takayoshi Masuoka, Takashi Yazawa. Role of Muscarinic Acetylcholine Receptors in Intestinal Epithelial Homeostasis: Insights for the Treatment of Inflammatory Bowel Disease. International Journal of Molecular Sciences 2023; 24(7) doi: 10.3390/ijms24076508
|
| 160 |
Yulia Liubomirski, Shalom Lerrer, Tsipi Meshel, Linor Rubinstein-Achiasaf, Dina Morein, Stefan Wiemann, Cindy Körner, Adit Ben-Baruch. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00757
|
| 161 |
Miles P. Sparrow. Adalimumab in ulcerative colitis – efficacy, safety and optimization in the era of treat-to target. Expert Opinion on Biological Therapy 2017; 17(5) doi: 10.1080/14712598.2017.1309390
|
| 162 |
Suhail Nurbhai, Kevin J. Roberts, Timothy M. Carlton, Luana Maggiore, Marion F. Cubitt, Keith P. Ray, Jill Reckless, Hafeez Mohammed, Peter Irving, Thomas T. MacDonald, Anna Vossenkämper, Michael R. West, Gareth C. Parkes, J. Scott Crowe. Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-50545-x
|
| 163 |
Tong Zhang, Guo‐Yan Liu, Jing‐Long Cao, Yan‐Nan Li, Hui Xue, Hai‐Tao Wu, Cheng‐Hao Jin. Peimine‐induced apoptosis and inhibition of migration by regulating reactive oxygen species‐mediated MAPK/STAT3/NF‐κB and Wnt/β‐catenin signaling pathways in gastric cancer MKN‐45 cells. Drug Development Research 2022; 83(7) doi: 10.1002/ddr.21987
|
| 164 |
Swati Dobhal, Mukesh Nandave, Vinod Tiwari, Mamta F Singh. Unveiling the potential of Cepharanthine from plant to patient- A comprehensive review of phytochemistry, pharmacology and clinical investigations. Journal of Biologically Active Products from Nature 2024; 14(1) doi: 10.1080/22311866.2024.2312835
|
| 165 |
Jaslin P. James, Boye Schnack Nielsen, Ebbe Langholz, Mikkel Malham, Estrid Høgdall, Lene Buhl Riis. Estimating tissue-specific TNF mRNA levels prior to anti-TNFα treatment may support therapeutic optimisation in IBD patients. Scandinavian Journal of Gastroenterology 2023; 58(11) doi: 10.1080/00365521.2023.2217313
|
| 166 |
Zejin Liu, Xinli Niu, Junpeng Wang. Naringenin as a natural immunomodulator against T cell-mediated autoimmune diseases: literature review and network-based pharmacology study. Critical Reviews in Food Science and Nutrition 2023; 63(32) doi: 10.1080/10408398.2022.2092054
|
| 167 |
Virginie Millet, Thomas Gensollen, Michael Maltese, Melanie Serrero, Nathalie Lesavre, Christophe Bourges, Christophe Pitaval, Sophie Cadra, Lionel Chasson, Thien Phong Vu Man, Marion Masse, Juan Jose Martinez-Garcia, Fabrice Tranchida, Laetitia Shintu, Konrad Mostert, Erick Strauss, Patricia Lepage, Mathias Chamaillard, Achille Broggi, Laurent Peyrin-Biroulet, Jean-Charles Grimaud, Philippe Naquet, Franck Galland. Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis. Gut 2023; 72(6) doi: 10.1136/gutjnl-2021-325792
|
| 168 |
Andrea Picchianti-Diamanti, Maria M. Rosado, Raffaele D’Amelio. Infectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis. Frontiers in Microbiology 2018; 8 doi: 10.3389/fmicb.2017.02696
|
| 169 |
Xiao-Zhi Li, Yun Qiu, Louisa Jeffery, Fen Liu, Rui Feng, Jin-Shen He, Jin-Yu Tan, Zi-Yin Ye, Si-Nan Lin, Subrata Ghosh, Marietta Iacucci, Min-Hu Chen, Ren Mao. Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19. Frontiers in Medicine 2021; 7 doi: 10.3389/fmed.2020.613475
|
| 170 |
Bingran Wang, Jun Shen. NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.895636
|
| 171 |
Sang Hoon Lee, Jae Geun Song, Hyo-Kyung Han. Site-selective oral delivery of therapeutic antibodies to the inflamed colon via a folic acid-grafted organic/inorganic hybrid nanocomposite system. Acta Pharmaceutica Sinica B 2022; 12(11) doi: 10.1016/j.apsb.2022.06.006
|
| 172 |
Marcel Vetter, Markus F. Neurath. Treatment Perspectives in Crohn’s Disease. Digestion 2018; 98(3) doi: 10.1159/000488449
|
| 173 |
Lieven Pouillon, Johan Van Stappen, Peter Bossuyt, Silvio Danese, Laurent Peyrin-Biroulet. Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?. Best Practice & Research Clinical Gastroenterology 2018; doi: 10.1016/j.bpg.2018.05.006
|
| 174 |
Jessica Codesido, Lara García-Varela, Xurxo García-Otero, Sheila Bouzón-Barreiro, Noemí Gómez-Lado, Francisco José Toja-Camba, Cristina Mondelo-García, Héctor Lazaré, Julia Baguña Torres, Jana Vidal-Otero, Santiago Medin-Aguerre, Alejandro Sanchez-Crespo, Francisco J. Otero-Espinar, José R. Herance, Anxo Fernández-Ferreiro, Pablo Aguiar. PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model. International Journal of Pharmaceutics 2025; 669 doi: 10.1016/j.ijpharm.2024.125011
|
| 175 |
Rishabh Hirawat, Mohd Aslam Saifi, Chandraiah Godugu. Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications. Life Sciences 2021; 267 doi: 10.1016/j.lfs.2020.118923
|
| 176 |
Marianna Lucafò, Raffaella Franca, Davide Selvestrel, Debora Curci, Letizia Pugnetti, Giuliana Decorti, Gabriele Stocco. Pharmacogenetics of treatments for inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(12) doi: 10.1080/17425255.2018.1551876
|
| 177 |
Beatriz del Rio, Begoña Redruello, Maria Fernandez, M. Cruz Martin, Victor Ladero, Miguel A. Alvarez. Lactic Acid Bacteria as a Live Delivery System for the in situ Production of Nanobodies in the Human Gastrointestinal Tract. Frontiers in Microbiology 2019; 9 doi: 10.3389/fmicb.2018.03179
|
| 178 |
Daisuke Tateiwa, Hideki Yoshikawa, Takashi Kaito. Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review. Cells 2019; 8(8) doi: 10.3390/cells8080818
|
| 179 |
Irene Soleto, Samuel Fernández-Tomé, Irene Mora-Gutiérrez, Montserrat Baldan-Martin, Cristina Ramírez, Cecilio Santander, José Andrés Moreno-Monteagudo, María José Casanova, Fernando Casals, Sergio Casabona, Irene Becerro, María Chaparro, David Bernardo, Javier P. Gisbert. Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease. Biomedicines 2022; 10(8) doi: 10.3390/biomedicines10081885
|
| 180 |
Soojung Hahn, Gyuri Kim, Sang-Man Jin, Jae Hyeon Kim. Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model. Biochemical and Biophysical Research Communications 2024; 690 doi: 10.1016/j.bbrc.2023.149291
|
| 181 |
Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama, Yasuo Suzuki. Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance. Intestinal Research 2022; 20(3) doi: 10.5217/ir.2021.00032
|
| 182 |
Lili Hu, Handan Tan, Qingfeng Cao, Gangxiang Yuan, Changwei Huang, Guannan Su, Aize Kijlstra, Peizeng Yang. Weak association of a TNFRSF1A polymorphism with Behcet's disease in Chinese Han. Experimental Eye Research 2020; 196 doi: 10.1016/j.exer.2020.108045
|
| 183 |
Hannah Schneider, Evelin Berger, Brendan Dolan, Beatriz Martinez-Abad, Liisa Arike, Thaher Pelaseyed, Gunnar C. Hansson. The human transmembrane mucin MUC17 responds to TNFα by increased presentation at the plasma membrane. Biochemical Journal 2019; 476(16) doi: 10.1042/BCJ20190180
|
| 184 |
Mudassir Alam, Kashif Abbas. Disruption of Islet β-Cells Integrity via TNF-α Activated Apoptotic Signalling in Acute Pancreatitis. Romanian Journal of Preventive Medicine 2026; 4(1) doi: 10.3390/rjpm4010001
|